Lebrikizumab Monotherapy Reduces Flares in Patients with Moderate-to-Severe Atopic Dermatitis
Domains
Life Sciences [q-bio]Origin | Publisher files allowed on an open archive |
---|---|
Licence |
Origin | Publisher files allowed on an open archive |
---|---|
Licence |
Pascal Lallemant : Connect in order to contact the contributor
https://hal.inrae.fr/hal-04248019
Submitted on : Thursday, October 19, 2023-9:51:41 AM
Last modification on : Friday, April 12, 2024-6:32:06 PM
Long-term archiving on: Saturday, January 20, 2024-6:21:14 PM